A significant breakthrough in cancer investigation is emerging with the use of VHH fragments to reactivate damaged p53. This crucial malignant inhibitor protein is frequently lost in several types of tumors, resulting https://pr1bookmarks.com/story22496890/vhh-fragments-reactivate-tumor-suppressor-p53-a-new-approach-for-tumor-therapy